Log In

Part Description

LP212196-2   Methotrexate tetraglutamate
Methotrexate (MTX) is a drug that is used to treat certain types of cancer as well as auto-immune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus and psoriasis. After uptake of MTX into cells, MTX is activated by the addition of glutamate residues and forms methotrexate polyglutamates (MTX-PGs), which are named based on the number of added glutamate residues (e.g. methotrexate triglutamate, MTX-PG3). The half-life of MTX in plasma is only several hours where as MTX PGs can persist in cells for weeks or months. PMID: 15677700 While high-dose MTX in the treatment of malignancy is due to the direct effect on tetrahydrofolate reductase and DNA synthesis, the long-term immune modulation of low-dose MTX therapy appears to be related to multiple metabolic effects of the MTX PGs. PMID: 20665136 Red blood cell MTX PG levels may be a marker for therapeutic response in patients treated with low-dose MTX, and low red blood cell MTX PG has been associated with poor clinical status in patients with RA. PMID: 15677700 Source: Regenstrief LOINC, PMID: 15677700

LOINC Names Get Info

Fully-Specified Name
Methotrexate tetraglutamate:SCnc:Pt:RBC:Qn:
Long Common Name
Methotrexate tetraglutamate [Moles/volume] in Red Blood Cells
Short Name
MTX-PG4 RBC-sCnc
Display Name
Methotrexate tetraglutamate (RBC) [Moles/Vol]
Consumer Name Alpha Get Info
Methotrexate tetraglutamate, Red blood cells

Part Model Get Info

  • Component
    Methotrexate tetraglutamate
    LP212196-2
    • Analyte
      Methotrexate tetraglutamate
      LP212196-2
      • Component Numerator
        Methotrexate tetraglutamate
        LP212196-2
        • Component Numerator Core
          Methotrexate tetraglutamate
          LP212196-2
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    SCnc
    LP6860-3
  • Time
    Pt
    LP6960-1
  • System
    RBC
    LP7536-8
    • System Core
      RBC
      LP7536-8
    • Super System
      NULL
       
  • Scale
    Qn
    LP7753-9
  • Method
    NULL
     

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.56
Last Updated
Version 2.73 (MIN)
Order vs. Observation
Both
Common Test Rank Get Info
14415

Member of these Panels

LOINCLong Common Name
81630-6Methotrexate polyglutamates 1-5 and total panel - Red Blood Cells

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Metotrexát tetraglutamát:Látková koncentrace:Časový bod:Erytrocyty:Kvantitativní:
el-GRGreek (Greece)Μεθοτρεξάτη τετραγλουταμική:SCnc:Pt:Ερυθρά αιμοσφαίρια:Qn:
Synonyms: DRUG/TOX Pt Qn SCnc Ερυθρά αιμοσφαίρια Μεθοτρεξάτη Μεθοτρεξάτη τετραγλουταμική
es-ESSpanish (Spain)Metotrexato-tetraglutamato:Concentración de sustancia:Punto temporal:Glóbulos rojos:Qn:
Synonyms: Cuantitativo
es-MXSpanish (Mexico)Tetraglutamato de metotrexato:Concentración de sustancias:Punto temporal:Eritrocitos:Cuantitativo:
fr-FRFrench (France)Méthotrexate tétraglutamate:Moles/Volume:Ponctuel:Érythrocytes:Numérique:
it-ITItalian (Italy)Methotrexate tetraglutammato:SCnc:Pt:RBC:Qn:
Synonyms: Concentrazione di Sostanza Globuli rossi Livelli farmacologici e tossicologia Punto nel tempo (episodio)
zh-CNChinese (China)氨甲喋呤四谷氨酸:物质的量浓度:时间点:红细胞:定量型:
Synonyms: C20H22N8O5;甲氨喋呤;氨甲基叶酸;氨甲蝶呤;甲基蝶啶胺;甲基蝶啶胺(化学不孕剂) MTX-PG4;氨甲喋呤-四谷氨酸;氨甲喋呤（甲氨喋呤、氨甲基叶酸、氨甲蝶呤、甲基蝶啶胺）四谷氨酸;氨甲喋呤多聚谷氨酸 4 RBC;RBCS;红血球;红血细胞;赤血球 克分子浓度;克分子浓度(单位体积);摩尔浓度;摩尔浓度(单位体积);物质的量浓度(单位体积) 可用数量表示的;定量性;数值型;数量型;连续数值型标尺 时刻;随机;随意;瞬间 毒品 毒品类 药品类 药物 药物/毒理学;药物/毒理学试验;药物毒理学试验;药物毒理学试验类 药物类

Example Units

UnitSource
nmol/L{RBCs}Example UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=81625-6